Financial Metrics Check: Amphastar Pharmaceuticals Inc (AMPH)’s Ratios for Trailing Twelve Months

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

As of close of business last night, Amphastar Pharmaceuticals Inc’s stock clocked out at $41.30, down -2.53% from its previous closing price of $42.37. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 0.57 million shares were traded. AMPH stock price reached its highest trading level at $43.215 during the session, while it also had its lowest trading level at $41.27.


To gain a deeper understanding of AMPH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 2.18. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.93.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on March 05, 2024, initiated with a Overweight rating and assigned the stock a target price of $60.

On November 17, 2023, BofA Securities started tracking the stock assigning a Neutral rating and target price of $63.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’24 when Petersen Floyd F. sold 500 shares for $41.67 per share. The transaction valued at 20,837 led to the insider holds 78,833 shares of the business.

Petersen Floyd F. sold 500 shares of AMPH for $21,714 on Apr 01 ’24. The Director now owns 79,333 shares after completing the transaction at $43.43 per share. On Mar 06 ’24, another insider, PETERS WILLIAM J, who serves as the CFO, EVP & TREASURER of the company, sold 18,136 shares for $46.48 each. As a result, the insider received 842,883 and left with 111,490 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 2071975552 and an Enterprise Value of 2357211136. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.23, and their Forward P/E ratio for the next fiscal year is 9.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.98 while its Price-to-Book (P/B) ratio in mrq is 3.00. Its current Enterprise Value per Revenue stands at 3.486 whereas that against EBITDA is 9.205.

Stock Price History:

Over the past 52 weeks, AMPH has reached a high of $67.66, while it has fallen to a 52-week low of $38.43. The 50-Day Moving Average of the stock is -2.90%, while the 200-Day Moving Average is calculated to be -18.40%.

Shares Statistics:

It appears that AMPH traded 417.52K shares on average per day over the past three months and 395400 shares per day over the past ten days. A total of 48.07M shares are outstanding, with a floating share count of 35.14M. Insiders hold about 28.09% of the company’s shares, while institutions hold 67.39% stake in the company. Shares short for AMPH as of 1714435200 were 3987025 with a Short Ratio of 9.55, compared to 1711584000 on 3674842. Therefore, it implies a Short% of Shares Outstanding of 3987025 and a Short% of Float of 12.43.

Most Popular

[the_ad id="945"]